Abstract:Background Metabolic reprogramming in cancer cells is likely to interact with the epigenetic landmarks, which may modulate tumorigenesis. However, the exact mechanism is still largely unknown. In our previous study, inhibition of activity of mechanistic target of rapamycin (mTORC1), a nutrient sensor that affects cellular metabolism, was able to attenuate the DNA methylation level. In this study, we aim to clarify the correlation between the metabolism and DNA methylation and evaluate their interactive roles in the pathogenesis of hepatocellular carcinoma (HCC). Methods We treated HCC cell lines with rapamycin to inhibit mTORC1 activity and performed immunofluorescence (IF) and Enzyme-linked immune sorbent assay (ELISA) to detect the levels of 5-methylcytosine (5-mC). Western-blot and IF assays were used to detect the protein levels of DNA methyltransferases (DNMTs) and RT-PCR was performed to test transcription of DNMTs. Cycloheximide was used to suppress the protein translation. Moreover, MG132 and BafA1 were used to inhibit the functions of ubiquitin-proteasome and autophagy-lysosome respectively to evaluate the effect of posttranslational modification for DNMTs degradation. Finally, we selected twenty liver cancer cell lines and combined western-blot and CCK8 assays to observe the association between mTORC1 inhibition-induced DNMTs degradation and cell viabilities. Results Rapamycin treatment reduced 5 mC levels in HCC cell lines. In parallel, mTORC1 inhibition attenuated the expressions of DNMT1. The subsequent experiments revealed that transcriptional regulation and posttranslational modification is not likely to participate in the process of DNMT1 degradation induced by mTORC1 inhibition. However, cycloheximide half-life assay indicated that mTORC1 might adjust the expression DNMT1 through regulating initial translational efficiency. We found that mTORC1-mediated DNMT1 degradation is closely linked to cell proliferation. Conclusions In conclusion, we demonstrated that mTORC1 could affect DNA methylation levels in HCC probably through regulating DNMTs expression. Besides, this interactive role seems to be closely linked to HCC cell viability. Investigation of the relationship between mTORC1 signalling and DNA methylation will deepen our insight on the pathogenesis of HCC and develop a novel therapeutic strategy for HCC patients.

Serine and one-carbon metabolism, a bridge that links mTOR signaling and DNA methylation in cancer

Serine Metabolic Reprogramming in Tumorigenesis, Tumor Immunity, and Clinical Treatment.

IDDF2018-ABS-0140 the Crosstalk of MTORC1 and DNA Methylation in Hepatocellular Carcinoma

Decoding Serine Metabolism: Unveiling Novel Pathways for Evolving Cancer Therapies

The Activation of Mtor Signalling Modulates DNA Methylation by Enhancing DNMT1 Translation in Hepatocellular Carcinoma.

Targeting serine-glycine-one-carbon metabolism as a vulnerability in cancers

Interplay between mTOR and Purine Metabolism Enzymes and Its Relevant Role in Cancer

Symphony of Epigenetic and Metabolic Regulation-Interaction Between the Histone Methyltransferase EZH2 and Metabolism of Tumor.

An Epigenetic Role of Mitochondria in Cancer

A comprehensive review on signaling attributes of serine and serine metabolism in health and disease

Regulation of redox homeostasis through DNA/RNA methylation and post-translational modifications in cancer progression

Serine and one-carbon metabolisms bring new therapeutic venues in prostate cancer

The role of serine metabolism in lung cancer: From oncogenesis to tumor treatment

Targeting methionine metabolism in cancer: opportunities and challenges

DNA Methylation: From Cancer Biology to Clinical Perspectives

Interplay Among Metabolism, Epigenetic Modifications, and Gene Expression in Cancer

Linking Cancer Metabolism to DNA Repair and Accelerated Senescence

Serine and one-carbon metabolism in cancer

Mtor Signaling Pathway and Cancer

Post-Transcriptional and Post-translational Regulation of Central Carbon Metabolic Enzymes in Cancer.